Chongqing Zhifei Biological Products Co., Ltd.
Announcement on Obtaining Drug Registration Certificate for Self-Developed Product Liraglutide Injection
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.
Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as the "Company") recently learned that its holding subsidiary, Chongqing Chengan Biopharmaceutical Co., Ltd. (hereinafter referred to as "Chengan Biopharmaceutical"), has obtained the "Drug Registration Certificate" for Liraglutide Injection issued by the National Medical Products Administration. The relevant situation is hereby announced as follows:
I. Basic Information of the Drug